LGND

NASDAQStock

Ligand Pharmaceuticals Incorporated

$209.96-11.28 (-5.10%)

52-Week Range

$96.67
$221.24

Key Stats

Market Cap

4.2B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03

Volume

340.1K

Avg Volume

205.6K

Performance

1M

+18.30%

3M

+16.72%

6M

+33.67%

YTD

+16.37%

1Y

+104.68%

3Y

+228.54%

5Y

+35.53%

Price Chart

ETF Exposure

LGND is held by 121 ETFs

ETFFund NameWeight
HELXFranklin Genomic Advancements ETF3.71%
PJPInvesco Pharmaceuticals ETF3.26%
PSCHInvesco S&P SmallCap Health Care ETF2.54%
AFSCabrdn Focused U.S. Small Cap Active ETF2.41%
XPHState Street SPDR S&P Pharmaceuticals ETF2.24%
BBPVirtus Biotech ETF1.71%
PTHInvesco Dorsey Wright Healthcare Momentum ETF1.30%
IHEiShares U.S. Pharmaceuticals ETF1.09%
RZGInvesco S&P SmallCap 600 Pure Growth ETF1.02%
GSCGoldman Sachs Small Cap Equity ETF0.92%
MMSCFirst Trust Multi-Manager Small Cap Opportunities ETF0.89%
XSMOInvesco S&P SmallCap Momentum ETF0.83%
FYCFirst Trust Small Cap Growth AlphaDEX Fund0.71%
SGRWHarbor Active Small Cap Growth ETF (SGRW)0.64%
BOUTInnovator IBD Breakout Opportunities ETF0.64%
OASCOneAscent Small Cap Core ETF0.63%
IJTiShares S&P Small-Cap 600 Growth ETF0.54%
SLYGState Street SPDR S&P 600 Small Cap Growth ETF0.54%
FTXHFirst Trust Nasdaq Pharmaceuticals ETF0.53%
QQQSInvesco NASDAQ Future Gen 200 ETF0.50%
VIOGVanguard S&P Small-Cap 600 Growth ETF0.48%
HEAL.LiShares Healthcare Innovation UCITS ETF0.47%
PILLDirexion Daily Pharmaceutical & Medical Bull 3X ETF0.44%
ESIXState Street SPDR S&P SmallCap 600 ESG ETF0.44%
SQLVRoyce Quant Small-Cap Quality Value ETF0.42%
USVMVictoryShares US Small Mid Cap Value Momentum ETF0.41%
DWASInvesco Dorsey Wright SmallCap Momentum ETF0.39%
FPXFirst Trust US Equity Opportunities ETF0.36%
QVMSInvesco S&P SmallCap 600 QVM Multi-factor ETF0.35%
FYXFirst Trust Small Cap Core AlphaDEX Fund0.34%
JPSEJPMorgan Diversified Return U.S. Small Cap Equity ETF0.34%
AVSCAvantis U.S. Small Cap Equity ETF0.34%
XJRiShares ESG Select Screened S&P Small-Cap ETF0.32%
IBBQInvesco Nasdaq Biotechnology ETF0.32%
IJRiShares Core S&P Small-Cap ETF0.28%
SPSMState Street SPDR Portfolio S&P 600 Small Cap ETF0.28%
IWNiShares Russell 2000 Value ETF0.25%
VIOOVanguard S&P Small-Cap 600 ETF0.24%
VTWVVanguard Russell 2000 Value ETF0.22%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF0.22%
BIBProShares - Ultra Nasdaq Biotechnology0.22%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.20%
SAAProShares - Ultra SmallCap6000.20%
BKSEBNY Mellon US Small Cap Core Equity ETF0.20%
AFSMFirst Trust Active Factor Small Cap ETF0.20%
STXKStrive Small-Cap ETF0.19%
FESMFIDELITY ENHANCED SMALL CAP ETF0.18%
SMLFiShares U.S. Small-Cap Equity Factor ETF0.16%
PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF0.15%
KBFRInnovator U.S. Small Cap Managed 10 Buffer ETF0.15%
Page 1 of 3Next

About LGND ETF Exposure

Ligand Pharmaceuticals Incorporated (LGND) is held by 121 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 4.2B, LGND is a widely held institutional stock. The stock currently trades at $209.96. Investors can gain exposure to LGND through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LGND, sorted by portfolio weight.